• 1
    Redberg RF. Informed strategies for treating coronary disease. Arch Intern Med 2012;172:321.
  • 2
    Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention: executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation 2011;124:25742609.
  • 3
    Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2012;59:857881.
  • 4
    Blankenship JC, Klein LW, Laskey WK, Krone RJ, Dehmer GJ, Chambers C, Cowley M. SCAI statement on ad hoc versus the separate performance of diagnostic cardiac catheterization and coronary intervention. Catheter Cardiovasc Interv 2004;63:444451.
  • 5
    Feldman RL, Macdonald RG, Hill JA, Conti R, Pepine CJ, Carmichael MJ, Knauff DG, Alexander JA. Coronary angioplasty at the time of initial cardiac catheterization. Cathet Cardiovasc Diagn 1986;12:219222.
  • 6
    Myler RK, Stertzer SH, Clark DA, Shaw RE, Fishman-Rosen J, Murphy MC. Coronary angioplasty at the time of initial cardiac catheterization. Cathet Cardiovasc Diagn 1986;12:213214.
  • 7
    Breisblatt WM, Ruffner RJ, Uretsky BF, Reddy PS. Same-day angioplasty and diagnostic catheterization: safe and effective but riskier in unstable angina. Angiology 1991;8:607613.
  • 8
    O'Keefe JH, Reeder GS, Miller GA, Bailey KR, Holmes DR. Safety and efficacy of percutaneous transluminal coronary angioplasty performed at time of diagnostic catheterization compared with that performed at other times. Am J Cardiol 1989;63:2729.
  • 9
    O'Keefe JH, Gernon C, McCallister BD, Ligon RW, Hartzler GO. Safety and cost effectiveness of ad hoc coronary angiography and angioplasty. Am Heart J 1991;122:5054.
  • 10
    Lund GK, Nienaber CA, Hamm CW, Terres W, Kuck KH. One session diagnostic heart catheterization and balloon dilatation (“prima-vista”-PTCA): Results and risks. Dtsch Med Wochenschr 1994;119:169174.
  • 11
    Rozenman Y, Gilon D, Zelingher J, Lotan C, Mosseri M, Geist M, Weiss AT, Hasin Y, Gotsman MS. One-stage coronary angiography and angioplasty. Am J Cardiol 1995;75:3033.
  • 12
    Kimmel SE, Berlin JE, Hennessy S, Strom BL, Krone RJ, Laskey WK. Risk of major complications from coronary angioplasty performed immediately after diagnostic coronary angiography: Results from the Registry of the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1997;30:193200.
  • 13
    Le Feuvre C, Helft G, Beygui F, Zerah T, Fonseca E, Catuli D, Batisse JP, Metzger JP. Safety, efficacy, and cost advantages of combined coronary angiography and angioplasty. J Interv Cardiol 2003;16:195199.
  • 14
    Panchamukhi V, Flaker GC. Should interventional cardiac catheterization procedures take place at the time of diagnostic procedures?Clin Cardiol 2000;23:332334.
  • 15
    Shubrooks SJ, Malenka DJ, Piper WD, Bradley WA, Watkins MW, Ryan TJ, Hettleman BD, VerLee PN, O'Meara JR, Robb JF, Kellett MA, Hearne MA, McGrath PD, Wennberg DE, O'Rourke DJ, Silver TM. Safety and efficacy of percutaneous coronary interventions performed immediately after diagnostic catheterization in northern New England and comparison with similar procedures performed later. Am J Cardiol 2000;86:4145.
  • 16
    Goldstein CL, Racz M, Hannan EL. Impact of cardiac catheterization-percutaneous coronary intervention timing on in-hospital mortality. Am Heart J 2002;144:561567.
  • 17
    Feldman DN, Minutello RM, Gade CL, Wong SC. Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (Report from the 2000 to 2001 New York State Angioplasty Registry). Am J Cardiol 2007;99:446449.
  • 18
    Krone RJ, Shaw RE, Klein LW, Blankenship JC, Weintraub WS; American College of Cardiology. Ad hoc percutaneous coronary interventions in patients with stable coronary artery disease—a study of prevalence, safety, and variation in use from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR). Catheter Cardiovasc Interv 2006;68:696703.
  • 19
    Hannan EL, Samadashvili Z, Walford G, Holmes DR, Jacobs A, Sharma S, Katz S, King SB. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. JACC Cardiovasc Interv 2009;2:350356.
  • 20
    Good CW, Blankenship JC, Scott TD, Skelding KA, Berger PB, Wood GC. Feasibility and safety of ad hoc percutaneous coronary intervention in the modern era. J Invasive Cardiol 2009;21:194200.
  • 21
    Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter SJ, Tijssen SGP, Lagerqvist B, Wallentin L. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol 2010;55:24352445.
  • 22
    Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:15031516.
  • 23
    Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley, K, Dawkins KD, Mohr FW. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961972.
  • 24
    Nallamothu B, Krumholz HM. Putting ad hoc PCI on pause. JAMA 2010;304:20592060.
  • 25
    Blankenship JC, Marshall JJ, Pinto DS, Lange RA, Bates ER, Holper EM, Grines CL, Chambers CE. Effect of percutaneous coronary intervention on quality of life: A consensus statement from the Society for Cardiovascular Angiography and Intervention. Cathet Cardiovasc Interv 2012; DOI: 10.1002/ccd.24376.
  • 26
    Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1988;12:529545.
  • 27
    Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO, Gibbons RJ, Alpert JP, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russel RO. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines). J Am Coll Cardiol 2001;37:22152239.
  • 28
    Tonino P, De Bruyne B, Pijls N, Siebert U, Ikeno F, van't Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd K, Ver Lee P, MacCarthy P, Fearon W. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213224.
  • 29
    Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, Bar F, Hoorntie J, Koolen J, Wijns W, de Bruyne B. Percutaneous coronary intervention of functionally non-significant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol 2007;49:21052111.
  • 30
    Vlaar PJ, Mahmoud KD, Holmes DR, van Valkenhoef G, Hillege HL, van der Horst ICC, Zilstra F, de Smet BJGL. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol 2011;58:692703.
  • 31
    Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006;295:25112515.
  • 32
    Webb JG, Lowe AM, Sanborn TA, Sleeper LA, Carere RG, Buller CE, Slater JN, Baran KW, Koller PT, Talley D, Porway M, Hochman JS. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 2003;42:13801386.
  • 33
    Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008;117:686697.
  • 34
    Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A. Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation 2002;106:804808.
  • 35
    Shishehbor MH, Lauer MS, Singh IM, Chew DP, Karha J, Brener SJ, Moliterno DJ, Ellis SG, Topol EJ, Bhatt DL. In unstable or non-ST-segment acute coronary syndrome, should patients with multi-vessel coronary artery disease undergo multi-vessel or culprit-only stenting?J Am Coll Cardiol 2007;49:849854.
  • 36
    Ijsselmuiden AJ, Ezechiels J, Westendorp ICD, Tijssen JGP, Kiemeneij F, Slagboom T, van der Wieken R, Tangelder G, Serruys PW, Laarman G. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: A randomized comparison. Am Heart J 2004;148:467474.
  • 37
    Palmer ND, Causer JP, Ramsdale DR, Perry RA. Effect of completeness of revascularization on clinical outcome in patients with multivessel disease presenting with unstable angina who undergo percutaneous coronary intervention. J Invasive Cardiol 2004;16:185188.
  • 38
    Dangas GD, George JC, Weintraub W, Popma JJ. Timing of staged percutaneous coronary intervention in multivessel coronary artery disease. JACC Cardiovasc Interv 2010;3:10961099.
  • 39
    Ahn JM, Kang SJ, Mintz GS, Oh JH, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Moon DH, Park SJ. Validation of minimal luminal area measured by intravascular ultrasound for assessment of functionally significant coronary stenosis comparison with myocardial perfusion imaging. JACC Cardiovasc Interv 2011;4:665671.
  • 40
    Kang SJ, Lee JY, Ahn JM, Mintz GS, Kim WJ, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Park SW, Park SJ. Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity. Circ Cardiovasc Interv 2011;4:6571.
  • 41
    Melikian N, De Bondt P, Tonino P, De Winter O, Wyffels E, Bartunek J, Heyndrickx GR, Fearon WF, Pijls NH, Wijns W, De Bruyne B. Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. JACC Cardiovasc Interv 2010:307314.
  • 42
    Blankenship JC, Moussa I, Brilakis ES, Chambers CE, Dehmer G, Morrison D. Staging of multi-vessel percutaneous coronary interventions. A consensus statement from the Society for Cardiovascular Angiography and Interventions. Cathet Cardiovasc Interv 2012;79:11381152.
  • 43
    de Labriolle A, Bonello L, Roy P, Lemesle G, Steinberg DH, Xue Z, Kaneshige K, Suddath WO, Satler LF, Kent KM, Pichard AD, Lindsay J, Waksman R. Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in “true” chronic total occlusions. Am J Cardiol 2008;102:11751181.
  • 44
    Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004;44:13931399.
  • 45
    Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, Cohen HA, Holmes DR. A pharmacokinetically-based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007;50:584590.
  • 46
    Frazier TH, Richardson JB, Fabre VC, Callen JP. Fluoroscopy-induced chronic radiation skin injury: A disease perhaps often overlooked. Arch Dermatol 2007;143:637640.
  • 47
    Chambers CE, Fetterly KA, Holzer R, Lin PJP, Blankenship JC, Balter S, Laskey WK. Radiation safety program for the cardiac catheterization laboratory. Catheter Cardiovasc Interv 2011;77:546556.
  • 48
    Blankenship JC. Progress towards doing the right thing. JACC Cardiovasc Interv 2012;5:236237.
  • 49
    Arnold SV, Decker C, Ahmad H, Olabiyi O, Mundluru S, Reid KJ, Soto GE, Gansert S, Spertus JA. Converting the informed consent from a perfunctory process to an evidence-based foundation for patient decision making. Circ Cardiovasc Qual Outcomes 2008;1:2122.
  • 50
    Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, Shaw RE, Roe MT, Ho KK, Klein LW, Krone RJ, Weintraub WS, Brindis RG, Rumsfeld JS, Spertus JA; NCDR Registry Participants. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol 2010;55:19231932.
  • 51
    Nam CW, Mangiacapra F, Enties R, Chung IS, Sels JW, Tonino PAL, De Bruyne B, Pijls NHJ, Fearon WF. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011;58:12111218.
  • 52
    Hochholzer W, Trenk D, Frundi D, Blanke P, Fischer B, Andris K, Bestehorn HP, Büttner HJ, Neumann FJ. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation 2005;111:25602564.
  • 53
    Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): Double-blind, randomised controlled trial. 2009;373:723731.
  • 54
    Klima T, Christ A, Marana I, Kalbermatter S, Uthoff H, Burri E, Hartwiger S, Schindler C, Breidthardt T, Marenzi G, Mueller C. Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: A randomized controlled trial. Eur Heart J 2012;33:20712079.
  • 55
    Adele C, Vaitkus PT, Wells SK, Zehnacker JB. Cost advantages of an ad hoc angioplasty strategy. J Am Coll Cardiol 1998;31:321325.